Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM200102013440503PMID 11172164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

  2000cited by this paper
• Bone Density of the Spine and Femur in Adult White Females

  1999cited by this paper
• Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

  1999cited by this paper
• Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

  1998cited by this paper
• How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study

  1998cited by this paper
• World-wide Projections for Hip Fracture

  1997cited by this paper
• Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III

  1997cited by this paper
• A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

  1997cited by this paper
• Body Size and Hip Fracture Risk in Older Women: A Prospective Study

  1997cited by this paper
• Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

  1997cited by this paper
• Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

  1997cited by this paper
• Fall-related factors and risk of hip fracture: the EPIDOS prospective study.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Estrogen Replacement Therapy and Fractures in Older Women

  1995cited by this paper
• Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• Prevalence of low femoral bone density in older U.S. women from NHANES III

  1995cited by this paper
• Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

  1994cited by this paper
• Case-control study of risk factors for hip fractures in the elderly.

  1994cited by this paper
• Risk of hip fracture in women with vertebral fracture

  1994cited by this paper
• Prevalence and incidence of vertebral deformities

  1993cited by this paper
• Prediction of osteoporotic fractures by postural instability and bone density.

  1993cited by this paper
• Vitamin D3 and calcium to prevent hip fractures in elderly women.

  1992cited by this paper
• Perspective how many women have osteoporosis?

  1992cited by this paper
• A model of lifetime osteoporosis impact.

  1991cited by this paper
• Risk of hip fracture among women with vertebral fractures

  1990cited by this paper
• Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

  1987cited by this paper
• POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS: A Case-control Study

  1979cited by this paper
• Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

  1979cited by this paper

• Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease.

  2026cites this paper
• A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women

  2025cites this paper
• The 2024 UK clinical guideline for the prevention and treatment of osteoporosis

  2025cites this paper
• Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against Senescence

  2025cites this paper
• Airway consequences of alendronic acid aspiration

  2025cites this paper
• Advancing care: optimizing osteoporosis treatment in the older and oldest old population

  2025influential citation
• Crosstalk between kidney and bones: New perspective for modulating osteoporosis.

  2025cites this paper
• Treatment of Osteoporosis and Osteoarthritis in the Oldest Old

  2025influential citation
• PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis

  2025cites this paper
• Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force.

  2025cites this paper
• The minimally invasive surgical local osteo-enhancement procedure (LOEP) to deliver a resorbable, tri-phasic calcium-based implant material to address bone loss and strengthen the proximal femur

  2025cites this paper
• Antiresorptive Therapy for Osteoporosis in Older Subjects

  2025cites this paper
• The effect of bisphosphonates on kidney function in osteoporotic geriatric patients with impaired renal function

  2025cites this paper
• Bisphosphonates and Periodontal Health: A Systematic Review in Postmenopausal Women

  2025cites this paper
• Anti-fracture efficacy of 5- or 10- yearly zoledronate in women aged 50-60y: secondary analyses of a randomized trial.

  2025cites this paper
• The Conundrum of Medical Fracture Prevention in Chronic Kidney Disease—Summary of the Evidence and Pragmatic Clinical Guidance

  2025cites this paper
• Efficacy of Osteoporosis Treatment in Nonagenarians With Proximal Femoral Fractures: A Retrospective Cohort Study

  2025cites this paper
• Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project

  2024cites this paper
• Existe-t-il une morphologie fémorale à risque de fracture cervicale ou pertrochantérienne ? Description et validation du « Neck shaft ratio » et du « Intertrochanteric distal ratio » après analyse d’une cohorte continue de 126 fractures bilatérales du fémur proximal

  2024cites this paper
• Bilateral Atypical Femoral Fracture in a Bisphosphonate-Naïve Patient with Prior Long-Term Denosumab Therapy: A Case Report of the Management Strategy and a Literature Review

  2024cites this paper
• Priority interventions for the prevention of falls or fractures in patients with osteoporosis: A network meta-analysis.

  2024cites this paper
• Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture

  2024cites this paper
• Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials

  2024influential citation
• Individuals with a fragility fracture and a prescription for bone active medication have a positive perception of the medication but do not associate it with fracture risk reduction

  2024cites this paper
• Is there a femoral morphology at risk of a cervical or pertrochanteric fracture? Description and validation of the "Neck shaft ratio" and the "Intertrochanteric distal ratio" after analyzing a continuous cohort of 126 bilateral fractures of the proximal femur.

  2024cites this paper
• Osteoking inhibits apoptosis of BMSCs in osteoporotic rats via PI3K/AKT signaling pathway.

  2024cites this paper
• Efficacy and safety of osteoporosis treatment in older adults. Approach for the secondary prevention of fractures in older populations. A proposal by SEFRAOS.

  2024cites this paper
• Efficacy of a Computerized Therapeutic Decision-Making Algorithm in a Fracture Liaison Service Targeting Hip Fracture Patients

  2024cites this paper
• Treatment Sequence for Osteoporosis.

  2024cites this paper
• Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  2024cites this paper
• A meta-analysis of previous falls and subsequent fracture risk in cohort studies

  2024cites this paper
• Erratum: Aktuelle und zukünftige pharmakologische Therapieoptionen zur Behandlung der Osteoporose und deren Wirkmechanismen – ein Überblick

  2024cites this paper
• Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis

  2024cites this paper
• Osteopenia: a key target for fracture prevention.

  2024cites this paper
• Airway consequences of alendronic acid aspiration

  2024cites this paper
• Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)

  2024cites this paper
• Factors Impacting Fall Severity in Hospitalized Patients: A Retrospective Cohort Study

  2024cites this paper
• Non-biological Antiresorptive: Bisphosphonates

  2023cites this paper
• Insights into the Mechanism of Osteoporosis and the Available Treatment Options.

  2023cites this paper
• Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials

  2023cites this paper
• Dementia, osteoporosis and fragility fractures: intricate epidemiological relationships, plausible biological connections, and twisted clinical practices.

  2023cites this paper
• Organized mineralized cellulose nanostructures for biomedical applications.

  2023cites this paper
• Association between bisphosphonate use and stroke risk: a meta-analysis

  2023cites this paper
• Osteoporosis and Fracture Risk among Older US Asian Adults

  2023cites this paper
• Management of High-Risk Ankle Fractures.

  2023cites this paper
• Combined and sequential therapies with anabolic and antiresorptive drugs in the management

  2023cites this paper
• Long-term and sequential treatment for osteoporosis

  2023cites this paper
• Bisphosphonate Use may be Associated with an Increased Risk of Periprosthetic Hip Fracture.

  2023cites this paper
• A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022

  2023cites this paper
• Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021

  2023cites this paper
• Use of vitamin D with anti-osteoporotic drugs: are available clinical trials telling us the whole story?

  2023cites this paper
• Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

  2023cites this paper
• Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?

  2023cites this paper
• A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

  2023cites this paper
• Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures.

  2023cites this paper
• Effect of a single dose of zoledronic acid on bone mineral density and trabecular bone score in Indian postmenopausal osteoporotic women with and without type 2 diabetes mellitus – A prospective cohort pilot study

  2023cites this paper
• Summary of the Thai Osteoporosis Foundation (TOPF) Clinical Practice Guideline on the diagnosis and management of osteoporosis 2021

  2023cites this paper
• Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects

  2023cites this paper
• A retrospective analysis of nonresponse to denosumab after hip fractures.

  2023cites this paper
• Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice

  2023influential citation
• The effects of osteoporosis education program for patients with fragility fracture in China.

  2023cites this paper
• Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools

  2023cites this paper
• A narrative review of the pharmaceutical management of osteoporosis

  2023cites this paper
• Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies.

  2023cites this paper
• Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases.

  2022cites this paper
• Fractures reduction with osteoporotic treatments in patients over 75-year-old: A systematic review and meta-analysis

  2022cites this paper
• General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study.

  2022cites this paper
• A Review on Management of Insufficiency Fractures of the Pelvis and Acetabulum.

  2022cites this paper
• The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance

  2022cites this paper
• Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.

  2022cites this paper
• Risk assessment tools for osteoporosis and fractures in 2022.

  2022cites this paper
• Polypharmacy in Osteoporosis Treatment.

  2022cites this paper
• Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials

  2022cites this paper
• Novel formulations of oral bisphosphonates in the treatment of osteoporosis

  2022cites this paper
• Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany

  2022cites this paper
• Efficacy of Antiresorptive Treatment in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2022influential citation
• Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials

  2022cites this paper
• What's New in Osteoporosis and Fragility Fractures.

  2022cites this paper
• Osteoporosis: An Update on Screening, Diagnosis, Evaluation, and Treatment.

  2022cites this paper
• Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial

  2022cites this paper
• How to implement guidelines and models of care.

  2022cites this paper
• Aminobisphosphonates: Reconsideration 25 years after their approval for the treatment of osteoporosis.

  2022cites this paper
• Plate Fixation for Atypical Fractures of the Femoral Diaphysis

  2022cites this paper
• Bone regeneration: A message from clinical medicine and basic science

  2022cites this paper
• Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data

  2022cites this paper
• Managing Musculoskeletal and Kidney Aging: A Call for Holistic Insights

  2022cites this paper
• Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan

  2022cites this paper
• Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk

  2022cites this paper
• Population screening for fracture risk in postmenopausal women — a logical step in reducing the osteoporotic fracture burden?

  2022cites this paper
• Improved outcomes and reduced medical costs through multidisciplinary co-management protocol for geriatric proximal femur fractures: a one-year retrospective study

  2022cites this paper
• The clinician’s guide to prevention and treatment of osteoporosis

  2022cites this paper
• Prevention of osteoporotic fracture: from skeletal and non-skeletal perspectives

  2022cites this paper
• Contemporaneous Insufficiency Fractures of Bilateral Femoral Necks in an Older Patient Taking Bisphosphonate: A Case Report and Literature Review

  2022cites this paper
• UK clinical guideline for the prevention and treatment of osteoporosis

  2022cites this paper
• Einfluss von Osteoporose auf physische Leistungsparameter von Personen im mittleren und höheren Lebensalter – eine Querschnittstudie

  2022cites this paper
• Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year

  2022cites this paper
• Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

  2022cites this paper
• review study on benefits of calcium supplementation on adolescent bone mineral density

  2022cites this paper
• Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis

  2022cites this paper
• Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  2022cites this paper